Neuropathology of multiple sclerosis lesions relevant to cerebrospinal fluid abnormalities

  • G. L. Mancardi
  • E. Capello


Multiple Sclerosis (MS) is the commonest organic disease of the Central Nervous System (CNS) in the young adult throughout the temperate zone. The hallmark is the demyelinating plaque, in which the removal of apparently normal myelin from axons, usually against a background of perivenular infiltration by lymphocytes, plasma cells and mononuclear cells, is observed.


Multiple Sclerosis Multiple Sclerosis Lesion Multiple Sclerosis Case Virchow Robin Space Multiple Sclerosis Brain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schelling F (1986) Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Medical Hypotheses 21: 141–148PubMedCrossRefGoogle Scholar
  2. 2.
    Peress NS, Siegelman J, Fleit HB (1987) High avidity periventricular IgG-Fc receptor activity in human and rabbit brain. Clin Immunol Immunopathol 42: 229–238PubMedCrossRefGoogle Scholar
  3. 3.
    Greenfield JG, Norman RM (1963) Demyelinating diseases. In: Blackwood W, McMenemey WH, Meyer A, Norman RM, Russell DS (eds) Greenfield’s Neuropathology. 2nd ed, Edward Arnold, London, pp 475–519Google Scholar
  4. 4.
    Sanders V, Conrad AJ, Tourtellotte WW (1993) On classification of postmortem multiple sclerosis plaques for neuroscientists. J Neuroimmunol 46: 207–216PubMedCrossRefGoogle Scholar
  5. 5.
    Raine CS, Traugott U (1990) The pathology of the myelinated axon. In: Adachi M and Sher JH (eds) Current Trends in Neurosciences-Neuromuseular diseases. Igaku-Shoin, New York, pp 229–275Google Scholar
  6. 6.
    Adams CWM, Abdulla YH, Torres EM, Poston RN (1987) Periventricular plaques in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neu-ropathol Appl Neurobiol 13: 141–152CrossRefGoogle Scholar
  7. 7.
    Prineas JW, Connell F (1979) Remyelination in multiple sclerosis. Ann Neurol 5: 22–31PubMedCrossRefGoogle Scholar
  8. 8.
    Raine CS, Scheinberg LC (1988) On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 20: 189–201PubMedCrossRefGoogle Scholar
  9. 9.
    Selmaj K, Brosnan CF, Raine CS (1991) Colocalization of lymphocytes bearing gamma delta receptor and heat shock protein hsp65 + oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci 88: 6452–6456PubMedCrossRefGoogle Scholar
  10. 10.
    Gerritse K, Deen C, Fasbender M, Ravid R, Boersma W, Claassen E(1994) The involvement of specific anti myelin basic protein antibody forming cells in multiple sclerosis immunopathology. J Neuroimmunol 49: 153–159Google Scholar
  11. 11.
    Noronha ABC, Richman DP, Arnason BGW (1980) Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry in patients with multiple sclerosis. New Eng J Med 303: 713–717PubMedCrossRefGoogle Scholar
  12. 12.
    Tournier-Lasserve E, Lyon-Caen O, Roullet E, Bach MA (1987) IL 2 receptor and HLA Class 2 antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. Clin Exp Immunol 67: 581–586PubMedGoogle Scholar
  13. 13.
    Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B71 and B72 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707–718PubMedCrossRefGoogle Scholar
  14. 14.
    De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisi F (1995) The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54: 175–187PubMedCrossRefGoogle Scholar
  15. 15.
    Hafler DA, Weiner HL (1995) Immunologic mechanisms and therapy in multiple sclerosis. Immunological Reviews 144: 75–107PubMedCrossRefGoogle Scholar
  16. 16.
    Romagnani S (1994) Lymphokine production by human T cells in disease states. Ann Rev Immunol 12: 227–257CrossRefGoogle Scholar
  17. 17.
    Gallo P, Piccinno M, Pagni S, Tavolato B (1988) Interleukin 2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 24: 795–797PubMedCrossRefGoogle Scholar
  18. 18.
    Trotter JL, Collins KG, Van der Veen R (1991) Serum cytokine levels in chronic progressive multiple sclerosis. Interleukin 2 levels parallel tumor necrosis factor alpha levels. J Neuroimmunol 33: 29–36PubMedCrossRefGoogle Scholar
  19. 19.
    Hintzen RQ, Van Lier RAW, Kuijpers KC, Baars PA, Schaasberg W, Lucas CJ, Polman CH (1991) Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 35: 211–217PubMedCrossRefGoogle Scholar
  20. 20.
    Olsson T, Wang WZ, Hojeberg B, Kostulas V, Jiang YP, Andersson G, Ekre HR, Link KH (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon gamma. J Clin Invest 86: 981–985PubMedCrossRefGoogle Scholar
  21. 21.
    Selmaj K, Raine CS, Cannella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949–954PubMedCrossRefGoogle Scholar
  22. 22.
    Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576PubMedCrossRefGoogle Scholar
  23. 23.
    Walsh MJ, Tourtellotte WW (1986) Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med 163: 41–53PubMedCrossRefGoogle Scholar
  24. 24.
    Prineas JW, Wright RG (1978) Macrophages, lymphocytes and plasmacells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38: 409–421PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • G. L. Mancardi
    • 1
  • E. Capello
    • 1
  1. 1.Department of Neurological SciencesUniversity of GenoaGenoaItaly

Personalised recommendations